Alps Advisors Inc Regeneron Pharmaceuticals, Inc. Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

A detailed history of Alps Advisors Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 310 shares of REGN stock, worth $233,439. This represents 0.0% of its overall portfolio holdings.

Number of Shares

310

Holding current value

$233,439

% of portfolio

0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1024.09 - $1201.76 $317,467 - $372,545	310 New	310 $325,000
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $7,751 - $8,817	-10 Reduced 2.5%	390 $342,000
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $17,311 - $21,109	-25 Reduced 5.88%	400 $329,000
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $3,500 - $4,151	5 Added 1.19%	425 $305,000
Q1 2023 May 10, 2023	BUY	$680.49 - $826.97 $285,805 - $347,327	420 New	420 $345,000
Q2 2022 Aug 11, 2022	SELL	$548.35 - $738.84 $2,741 - $3,694	-5 Reduced 0.95%	523 $309,000
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $24,995 - $29,334	-42 Reduced 7.37%	528 $369,000
Q4 2021 Feb 09, 2022	BUY	$543.48 - $670.97 $3,804 - $4,696	7 Added 1.24%	570 $360,000
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $323,178 - $383,380	563 New	563 $341,000
Q1 2021 May 07, 2021	SELL	$446.73 - $548.2 $203,708 - $249,979	-456 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$478.3 - $607.98 $530,434 - $674,249	-1,109 Reduced 70.86%	456 $220,000
Q3 2020 Nov 04, 2020	BUY	$544.75 - $658.21 $7,626 - $9,214	14 Added 0.9%	1,565 $876,000
Q2 2020 Aug 05, 2020	BUY	$493.32 - $643.92 $540,678 - $705,736	1,096 Added 240.88%	1,551 $967,000
Q1 2020 May 06, 2020	BUY	$336.18 - $494.43 $152,961 - $224,965	455 New	455 $222,000
Q3 2019 Nov 04, 2019	SELL	$273.46 - $318.39 $250,489 - $291,645	-916 Closed	0 $0
Q2 2019 Aug 07, 2019	SELL	$299.6 - $414.82 $14,380 - $19,911	-48 Reduced 4.98%	916 $287,000
Q1 2019 May 01, 2019	SELL	$372.08 - $439.57 $83,718 - $98,903	-225 Reduced 18.92%	964 $396,000
Q4 2018 Feb 04, 2019	SELL	$335.82 - $403.04 $16,791 - $20,152	-50 Reduced 4.04%	1,189 $444,000
Q3 2018 Oct 25, 2018	SELL	$351.14 - $408.51 $42,136 - $49,021	-120 Reduced 8.83%	1,239 $501,000
Q2 2018 Aug 02, 2018	BUY	$284.6 - $344.99 $2,561 - $3,104	9 Added 0.67%	1,359 $469,000
Q2 2018 Jul 25, 2018	SELL	$284.6 - $344.99 $87,656 - $106,256	-308 Reduced 18.58%	1,350 $508,000
Q1 2018 May 01, 2018	BUY	$315.82 - $393.78 $97,272 - $121,284	308 Added 22.81%	1,658 $571,000
Q4 2017 Feb 05, 2018	BUY	$358.63 - $469.95 $105,078 - $137,695	293 Added 27.72%	1,350 $508,000
Q3 2017 Nov 03, 2017	BUY	$431.38 - $504.0 $455,968 - $532,728	1,057	1,057 $473,000

Others Institutions Holding REGN

# of Institutions

1,532

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $80.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account